PRO MEDEX

Professional Medical Expertise Co.

9574StocksTadawulIndustrialsMarket closed

SAR 83.50

Official close

-1.8%

Price as of June 25, 2026 · Market close

Prices may be delayed by up to 30 minutes.

Financials

PRO MEDEX

Professional Medical Expertise Co.

9574StocksTadawulIndustrialsMarket closed

SAR 83.50

Official close

-1.8%

Price as of June 25, 2026 · Market close

Prices may be delayed by up to 30 minutes.

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Semi-annual

Annual (SAR)

1-5

	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021
Operations
Operating Cash Flow	0.72M	-1.88M	5.88M	-3.92M	21.03M
Free Cash Flow	-23.52M	-8.46M	-3.10M	-10.43M	17.69M
Capital Expenditures	-24.23M	-6.58M	-8.98M	-6.51M	-3.34M
Investing & Financing
Investing Cash Flow	-15.81M	-3.11M	-6.80M	-6.39M	-3.34M
Financing Cash Flow	14.05M	8.93M	-3.44M	-2.17M	-5.26M
Dividends Paid	-3.50M	-9.98M	—	-16.00M	-2.90M
Operating Activities
Operating Cash Flow	0.72M	-1.88M	5.88M	-3.92M	21.03M
Net Income	41.71M	27.65M	24.84M	19.02M	20.62M
Change in Accounts Payable	26.18M	-7.60M	47.69M	6.95M	28.71M
Change in Accounts Receivable	-91.28M	-6.51M	-37.55M	-14.57M	-33.12M
Change in Inventory	-9.30M	-33.97M	-40.43M	-25.19M	-13.39M
Change in Other Net Operating Assets	2.38M	-4.91M	-3.82M	-1.82M	11.14M
Change in Working Capital	-72.02M	-52.98M	-34.11M	-34.63M	-6.66M
Other Operating Activities	19.93M	14.46M	7.99M	6.23M	4.20M
Provision & Write-off of Bad Debts	3.32M	3.80M	2.79M	2.39M	0.44M
Depreciation & Amortization	8.62M	6.63M	5.45M	3.07M	2.37M
Cash Interest Paid	10.93M	10.37M	6.16M	4.33M	2.52M
Miscellaneous Cash Flow Adjustments	—	—	—	—	—
Asset Writedown & Restructuring Costs	842.53K	—	—	—	—
Investing Activities
Investing Cash Flow	-15.81M	-3.11M	-6.80M	-6.39M	-3.34M
Capital Expenditures	-24.23M	-6.58M	-8.98M	-6.51M	-3.34M
Cash Acquisitions	—	—	—	—	—
Sale of Property, Plant & Equipment	8.42M	3.47M	2.18M	0.12M	—
Loss (Gain) From Sale of Assets	-1.69M	-1.44M	-1.09M	-0.00M	0.06M
Financing Activities
Financing Cash Flow	14.05M	8.93M	-3.44M	-2.17M	-5.26M
Common Dividends Paid	-3.50M	-9.98M	—	-16.00M	-2.90M
Issuance of Common Stock	—	—	—	—	—
Short-Term Debt Issued	242.88M	221.00M	4.66M	18.79M	0.63M
Total Debt Issued	242.88M	221.00M	4.66M	18.79M	0.63M
Long-Term Debt Repaid	-2.88M	-1.85M	-1.94M	-0.63M	-0.47M
Short-Term Debt Repaid	-211.52M	-189.88M	—	—	—
Total Debt Repaid	-214.40M	-191.73M	-1.94M	-0.63M	-0.47M
Net Debt Issued (Repaid)	28.48M	29.27M	2.72M	18.16M	0.16M
Other Financing Activities	-10.93M	-10.37M	-6.16M	-4.33M	-2.52M
Free Cash Flow & Returns
Free Cash Flow	-23.52M	-8.46M	-3.10M	-10.43M	17.69M
Free Cash Flow Growth	—	—	—	—	+78.0%
Free Cash Flow Margin	-5.6%	-2.7%	-1.2%	-5.9%	+13.5%
Free Cash Flow Per Share	-6.72	-2.42	-0.89	-4.67	22.93
Levered Free Cash Flow	-47.45M	-29.59M	-17.53M	-48.46M	9.68M
Unlevered Free Cash Flow	-40.19M	-22.83M	-13.38M	-48.40M	9.68M
Operating Cash Flow Growth	—	—	—	—	+75.3%
Net Cash Flow	-1.04M	3.94M	-4.36M	-12.49M	12.43M

Income Statement Balance Sheet Cash Flow Ratios

Annual Semi-annual

Annual (SAR)

1-5

	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021
Operations
Operating Cash Flow	0.72M	-1.88M	5.88M	-3.92M	21.03M
Free Cash Flow	-23.52M	-8.46M	-3.10M	-10.43M	17.69M
Capital Expenditures	-24.23M	-6.58M	-8.98M	-6.51M	-3.34M
Investing & Financing
Investing Cash Flow	-15.81M	-3.11M	-6.80M	-6.39M	-3.34M
Financing Cash Flow	14.05M	8.93M	-3.44M	-2.17M	-5.26M
Dividends Paid	-3.50M	-9.98M	—	-16.00M	-2.90M
Operating Activities
Operating Cash Flow	0.72M	-1.88M	5.88M	-3.92M	21.03M
Net Income	41.71M	27.65M	24.84M	19.02M	20.62M
Change in Accounts Payable	26.18M	-7.60M	47.69M	6.95M	28.71M
Change in Accounts Receivable	-91.28M	-6.51M	-37.55M	-14.57M	-33.12M
Change in Inventory	-9.30M	-33.97M	-40.43M	-25.19M	-13.39M
Change in Other Net Operating Assets	2.38M	-4.91M	-3.82M	-1.82M	11.14M
Change in Working Capital	-72.02M	-52.98M	-34.11M	-34.63M	-6.66M
Other Operating Activities	19.93M	14.46M	7.99M	6.23M	4.20M
Provision & Write-off of Bad Debts	3.32M	3.80M	2.79M	2.39M	0.44M
Depreciation & Amortization	8.62M	6.63M	5.45M	3.07M	2.37M
Cash Interest Paid	10.93M	10.37M	6.16M	4.33M	2.52M
Miscellaneous Cash Flow Adjustments	—	—	—	—	—
Asset Writedown & Restructuring Costs	842.53K	—	—	—	—
Investing Activities
Investing Cash Flow	-15.81M	-3.11M	-6.80M	-6.39M	-3.34M
Capital Expenditures	-24.23M	-6.58M	-8.98M	-6.51M	-3.34M
Cash Acquisitions	—	—	—	—	—
Sale of Property, Plant & Equipment	8.42M	3.47M	2.18M	0.12M	—
Loss (Gain) From Sale of Assets	-1.69M	-1.44M	-1.09M	-0.00M	0.06M
Financing Activities
Financing Cash Flow	14.05M	8.93M	-3.44M	-2.17M	-5.26M
Common Dividends Paid	-3.50M	-9.98M	—	-16.00M	-2.90M
Issuance of Common Stock	—	—	—	—	—
Short-Term Debt Issued	242.88M	221.00M	4.66M	18.79M	0.63M
Total Debt Issued	242.88M	221.00M	4.66M	18.79M	0.63M
Long-Term Debt Repaid	-2.88M	-1.85M	-1.94M	-0.63M	-0.47M
Short-Term Debt Repaid	-211.52M	-189.88M	—	—	—
Total Debt Repaid	-214.40M	-191.73M	-1.94M	-0.63M	-0.47M
Net Debt Issued (Repaid)	28.48M	29.27M	2.72M	18.16M	0.16M
Other Financing Activities	-10.93M	-10.37M	-6.16M	-4.33M	-2.52M
Free Cash Flow & Returns
Free Cash Flow	-23.52M	-8.46M	-3.10M	-10.43M	17.69M
Free Cash Flow Growth	—	—	—	—	+78.0%
Free Cash Flow Margin	-5.6%	-2.7%	-1.2%	-5.9%	+13.5%
Free Cash Flow Per Share	-6.72	-2.42	-0.89	-4.67	22.93
Levered Free Cash Flow	-47.45M	-29.59M	-17.53M	-48.46M	9.68M
Unlevered Free Cash Flow	-40.19M	-22.83M	-13.38M	-48.40M	9.68M
Operating Cash Flow Growth	—	—	—	—	+75.3%
Net Cash Flow	-1.04M	3.94M	-4.36M	-12.49M	12.43M